Stroke [cerebrovascular accident].This serious spontaneous report was received from a pharmacist in united states.This report concerns a patient of unknown age and gender who experienced a stroke during treatment with euflexxa (sodium hyaluronate) solution for injection 1 %, unknown dose, for an unknown indication from an unknown start date to an unknown stop date.On an unknown date, the patient experienced stroke.The stroke was medically significant.Action taken with euflexxa was dose withdrawn.There was not reported any concomitant medication.This ae occurred in the united states and concerns medical device euflexxa.Please report to your local health authority if required by law.This ae is not reportable in the eu because it does not meet the definition of a medical device incident according to the requirements of the medical device directive, because it did not occur in an eu + efta country and did not result in a corrective action by the manufacturer.Overall listedness (core label) is unlisted.Reporter causality: related.Company causality: not related.Other case numbers: case number, others = (b)(4).
|